Imiquimod, 5% cream

Immunologic Profile of Chronically Photodamaged Skin

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Imiquimod for Preventing Keloid Recurrence

Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Imiquimod in Children With Plaque Morphea

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

1-Year Follow up to the 1473-IMIQ Study